Lonza sharpens pharma focus with CHF4.2B sale of Specialty Ingredients to Bain Capital and Cinven

Related Articles

FormattedPicture

NUTRITION & HEALTH NEWS

02 Apr 2021 --- In nutrition news this week, Dr. Paul Lohmann’s magnesium citrate malate was approved for food supplement fortification in Europe, and a study gave evidence... Read More

FormattedPicture

NUTRITION & HEALTH NEWS

25 Mar 2021 --- The COVID-19 pandemic has acted as a catalyst on the sports nutrition industry, propelling consumer awareness and demand for products aiding athletic activities... Read More

FormattedPicture

NUTRITION & HEALTH NEWS

24 Feb 2021 --- The category of performance nutraceuticals has undergone a dramatic shift in the last decade. Products traditionally aimed at boosting athletic enhancement have... Read More

FormattedPicture

NUTRITION & HEALTH NEWS

27 Jan 2021 --- Lonza has reported a “strong” performance for its 2020 financial year. Notably, the Capsules & Health Ingredients segment benefited from increased... Read More

FormattedPicture

NUTRITION & HEALTH NEWS

27 Jan 2021 --- New types of supplements are providing another way to ensure that people are consuming the nutrients they need to maintain their health.The COVID-19 pandemic has... Read More

trans